Fig. 4: Associations with clinical outcome. | Translational Psychiatry

Fig. 4: Associations with clinical outcome.

From: Modulation of inhibitory control networks relate to clinical response following ketamine therapy in major depression

Fig. 4

Average regional NoGo>Go contrast values in the right (a) and left (e) SMA ROI (in red) showed a significant association with HDRS scores. b Baseline (TP1) average regional NoGo>Go contrast values in the right SMA showed a significant negative relationship with serial change in HDRS (TP1–TP3); c Acute change (TP1-TP2) of average regional NoGo>Go contrast values in the right SMA showed a significant negative relationship with serial change (TP1–TP3) HDRS scores. d Serial change (TP1-TP3) of average regional NoGo>Go contrast values in the right SMA showed a significant negative relationship with serial change (TP1–TP3) HDRS scores. Similarly, f Baseline (TP1) average regional NoGo>Go contrast values in the left SMA showed a significant negative relationship with serial change in HDRS (TP1–TP3); g Acute change (TP1–TP2) of average regional NoGo>Go contrast values in the left SMA showed a significant negative relationship with serial change (TP1–TP3) HDRS scores. H) Serial change (TP1–TP3) of average regional NoGo>Go contrast values in the left SMA showed a significant negative relationship with serial change (TP1–TP3) HDRS scores R = right. L = left.

Back to article page